Page 61 - 南京医科大学自然版
P. 61

第45卷第2期 蔡清清,尤含笑,王 磊,等. NLR和SII对抗MDA5抗体阳性皮肌炎伴快速进展型肺炎的预后价值[J].
                  2025年2月                     南京医科大学学报(自然科学版),2025,45(2):196-207                        ·201 ·


                                                +
                                  表2 anti⁃MDA5 DM患者发生RPILD独立危险因素的单因素和多因素分析
                   Table 2 Univariate and multivariate analysis of the independent risk factors of RPILD in anti⁃MDA5 DM patients
                                                                                                  +
                                                         Univariate                         Multivariate
                         Variable
                                              P                  HR(95%CI)            P          HR(95%CI)
                    Age                      0.022       00 000 001.03(1.01-1.06)    0.141      1.02(0.99-1.05)
                    Sex                      0.364       00 000 001.35(0.71-2.58)     -               -
                    NLR                     <0.001       00 000 001.13(1.06-1.20)    0.003      1.11(1.03-1.18)
                    PLR                      0.012       00 000 001.00(1.00-1.00)     -               -
                    LMR                      0.037       00 000 000.66(0.44-0.98)     -               -
                    SII                      0.003       00 000 001.00(1.00-1.00)     -               -
                    SIRI                     0.003       00 000 001.21(1.07-1.36)     -               -
                    AISI                     0.015       00 000 001.00(1.00-1.00)     -               -
                    Myasthenia               0.179       00 000 001.56(0.82-2.98)     -               -
                    Gottron’s sign           0.084       00 000 000.57(0.30-1.08)    0.146      0.62(0.32-1.18)
                    Heliotrope rash          0.068       00 000 000.54(0.28-1.05)    0.156      0.61(0.31-1.21)
                    V sign                   0.658       00 000 000.86(0.43-1.70)     -               -
                    Shawl sign               0.220       00 000 000.58(0.24-1.39)     -               -
                    Skin erythema            0.369       00 000 000.78(0.35-1.48)     -               -
                    Raynaud’s phenomenon     0.716       00 000 000.69(0.10-5.04      -               -
                    Periungual erythema      0.380       00 000 000.66(0.26-1.68)     -               -
                    Arthritis                0.442       00 000 000.76(0.35-1.58)     -               -
                    Mechanic’s hand          0.239       00 000 000.66(0.32-1.33)     -               -
                    Heterotopic calcification  0.998     00 000 000.00(0-Inf)         -               -
                    Skin ulcer               0.227       00 000 000.53(0.19-1.49)     -               -
                    Hypertension             0.534       00 000 001.26(0.61-2.60)     -               -
                    Diabetes                 0.423       00 000 000.62(0.19-2.01)     -               -
                    Malignant tumor          0.996       00 000 000.00(0-Inf)         -               -
                    Cardiac involvement      0.234       00 000 000.30(0.04-2.18)     -               -
                    ILD                      0.996       79 944 617.47(0-Inf)         -               -
                    Glu                      0.202       00 000 001.55(0.79-3.05)     -               -
                   PLR:platelet⁃to⁃lymphocyte ratio;NLR:neutrophil⁃to⁃lymphocyte ratio;LMR:lymphocyte⁃to⁃monocyte ratio;SII:systemic immune⁃inflammation
                index;SIRI:systemic inflammation response index;ILD:interstitial lung disease;Glu:glucose;Inf:infinity;CI:confidence interval.


                3B).                                              the current study,we aimed to screen prognostic fac⁃
                                                                                       +
                                                                  tors affecting anti⁃MDA5 DM and highlight its poten⁃
                3 Discussion
                                                                  tial significance in clinical practice.
                              +
                    Anti⁃MDA5 DM is frequently associated with in⁃    We found that the NLR was the most significant
                terstitial lung disease,particularly RPILD which has  prognostic biomarker for RPILD in patients with anti⁃
                                       [1]                              +
                impressively high mortality . The interactions of pe⁃  MDA5 DM. According to previous studies,NLR was an
                ripheral blood cells play a crucial role in regulating in⁃  important marker for evaluating the activity of RA [41- 42]
                flammation and immune responses. Neutrophils,lym⁃  and predicting the risk of death [43] . Additionally,NLR
                phocytes,and platelets are vital effector cells in the  was associated with the activity of leukoaraiosis syn⁃
                                  [38- 40]                             [44- 45]                          [46- 47]
                inflammatory response  . Consequently,the derived  drome   and a predictor of psoriatic arthritis  . It
                inflammatory indices,such as NLR and SII,have     has also been correlated with the activity of systemic
                gained attention for their ability to comprehensively as⁃  lupus erythematosus and the prediction of lupus ne⁃
                                                                       [48]
                sess the inflammatory status in patients with systemic  phritis  . In cases of pulmonary fibrosis in ILD,fibro⁃
                                                     +  [12]
                autoimmune diseases,including anti⁃MDA5 DM  . In  blasts and myofibroblasts proliferate and deposit exces⁃
   56   57   58   59   60   61   62   63   64   65   66